Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp>karos and <scp>A</scp>iolos via modulation of the <scp>E</scp>3 ubiquitin ligase complex <scp>CRL</scp>4<scp><sup>CRBN</sup></scp>
Distribution of the number of citations over years.